Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018

Background: In 2019, the World Health Organization released guidelines reflecting major changes in multidrug-resistant tuberculosis (MDR-TB) management—prioritizing fluoroquinolones, bedaquiline, and linezolid (LZD) while de-emphasizing previously favored injectable agents. In some cases, linezolid...

Full description

Bibliographic Details
Main Authors: Ashley McDowell, Michelle Haas, Barbara Seaworth, John W. Wilson, Amee Patrawalla, Connie Haley, Mike Lauzardo, Miko de Bruyn, Neela D. Goswami
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Subjects:
Tuberculosis
Linezolid
Drug resistance
Multi-drug resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2405579420300656

Internet

http://www.sciencedirect.com/science/article/pii/S2405579420300656

Similar Items